Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 6
Submit an article Journal homepage
945
Views
2
CrossRef citations to date
0
Altmetric
Short Report

Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia

Vesa LindströmDepartment of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5724-9120
ORCID Icon,
Janne AittoniemiDepartment of Clinical Microbiology, Fimlab Laboratories, Tampere, Finland
,
Urpu SalmenniemiDepartment of Hematology and Stem Cell Transplantation Unit, Division of Medicine, Turku University Hospital, Turku, Finland
,
Helena KäyhtyDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland
,
Heini HuhtalaFaculty of Social Sciences, University of Tampere, Tampere, Finland
,
Maija Itälä-RemesDepartment of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, HUS, Helsinki, Finland
&
Marjatta SinisaloDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland
 show all
Pages 1471-1474 | Received 07 Nov 2017, Accepted 29 Jan 2018, Published online: 23 Feb 2018

References

  • Linet MS, Schubauer-Berigan MK, Weisenburger DD, Richardson DB, Landgren O, Blair A, Silver S, Field RW, Caldwell G, Hatch M, et al. Chronic lymphocytic leukaemia: An overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol. 2007;139(5):672–686. doi:10.1111/j.1365-2141.2007.06847.x. PMID:18021081.
  • Dearden C. Disease-specific complications of chronic lymphocytic leukemia. ASH Education Program Book. 2008;2008:450–456. doi:10.1182/asheducation-2008.1.450. PMID:19074125.
  • Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 2015;126(5):573–581. doi:10.1182/blood-2015-03-567388. PMID:26084672.
  • Morrison VA. Infectious complications of chronic lymphocytic leukaemia: Pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol. 2010;23(1):145–153. doi:10.1016/j.beha.2009.12.004. PMID:20620978.
  • Sinisalo M, Aittoniemi J, Oivanen P, Käyhty H, Ölander R, Vilpo J. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol. 2001;114(1):107–110. doi:10.1046/j.1365-2141.2001.02882.x. PMID:11472353.
  • Hartkamp A, Mulder AH, Rijkers GT, van Velzen-Blad H, Biesma DH. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine. 2001;19(13–14):1671–1677. doi:10.1016/S0264-410X(00)00409-6. PMID:11166890.
  • Safdar A, Rodriguez GH, Rueda AM, Wierda WG, Ferrajoli A, Musher DM, O'Brien S, Koller CA, Bodey GP, Keating MJ. Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: A prospective, randomized trial of safety and immunogenicity. Cancer. 2008;113(2):383–387. doi:10.1002/cncr.23561. PMID:18470901.
  • Van der Velden AM, Van Velzen-Blad H, Claessen AM, Van der Griend R, Oltmans R, Rijkers GT, Biesma DH. The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia. Eur J Haematol. 2007;79(1):47–52. doi:10.1111/j.1600-0609.2007.00862.x. PMID:17532765.
  • Sinisalo M, Vilpo J, Itälä M, Väkeväinen M, Taurio J, Aittoniemi J. Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine. 2007;26(1):82–87. doi:10.1016/j.vaccine.2007.10.053. PMID:18053620.
  • Pasiarski M, Rolinski J, Grywalska E, Stelmach-Goldys A, Korona-Glowniak I, Gozdz S, Hus I, Malm A. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients-preliminary report. PLoS One. 2014;9(12):e114966. doi:10.1371/journal.pone.0114966. PMID:25506837.
  • Simell B, Lahdenkari M, Reunanen A, Kayhty H, Vakevainen M. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol. 2008;15(9):1391–1397. doi:10.1128/CVI.00110-08. PMID:18596205.
  • Jodar L, Butler J, Carlone G, Dagan R, Goldblatt D, Kayhty H, Klugman K, Plikaytis B, Siber G, Kohberger R, et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine. 2003;21(23):3265–3272. doi:10.1016/S0264-410X(03)00230-5. PMID:12804857.
  • Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI, International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams. Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy. Vaccine. 2013;31(42):4782–4790. doi:10.1016/j.vaccine.2013.08.002. PMID:23954381.
  • Frenck RW, Jr., Fiquet A, Gurtman A, van Cleeff M, Davis M, Rubino J, Smith W, Sundaraiyer V, Sidhu M, Emini EA, et al. Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine. 2016;34(30):3454–3462. doi:10.1016/j.vaccine.2016.04.093. PMID:27155493.
  • Cordonnier C, Labopin M, Robin C, Ribaud P, Cabanne L, Chadelat C, Cesaro S, Ljungman P. Long-term persistence of the immune response to antipneumococcal vaccines after allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Bone Marrow Transplant. 2015;50(7):978–983. doi:10.1038/bmt.2015.42. PMID:25867652.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.